Vivani Medical (VANI) News Today $1.20 +0.06 (+5.26%) Closing price 04:00 PM EasternExtended Trading$1.22 +0.02 (+1.25%) As of 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VANI Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani ShareholdersMay 29 at 9:33 AM | finance.yahoo.comHC Wainwright Estimates Vivani Medical Q1 EarningsVivani Medical, Inc. (NASDAQ:VANI - Free Report) - Research analysts at HC Wainwright issued their Q1 2026 EPS estimates for shares of Vivani Medical in a research note issued on Monday, May 19th. HC Wainwright analyst Y. Chen anticipates that the company will earn ($0.09) per share for the quartMay 24, 2025 | marketbeat.comHC Wainwright Weighs in on Vivani Medical Q1 EarningsMay 23, 2025 | americanbankingnews.comVivani Medical (NASDAQ:VANI) Receives Buy Rating from HC WainwrightHC Wainwright reissued a "buy" rating and issued a $4.00 price objective on shares of Vivani Medical in a research note on Monday.May 21, 2025 | marketbeat.comHC Wainwright Reiterates Buy Rating for Vivani Medical (NASDAQ:VANI)May 21, 2025 | americanbankingnews.comVivani Medical Reports Q1 2025 Results and Strategic UpdatesMay 20, 2025 | tipranks.comVivani Medical, Inc.: Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial ResultsMay 15, 2025 | finanznachrichten.deVivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial ResultsMay 13, 2025 | globenewswire.comVivani Medical CEO to Present on Innovative Drug Delivery Solutions at AAPS Virtual WorkshopMay 9, 2025 | nasdaq.comVivani Medical (VANI) Projected to Post Earnings on MondayVivani Medical (NASDAQ:VANI) will be releasing its Q1 2025 earnings before the market opens on Monday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-12-vivani-medical-inc-stock/)May 7, 2025 | marketbeat.comVivani Medical to Present at the American Association of Pharmaceutical Scientists' “Beyond GLP1s: Where the Science will Take Business Next” Virtual WorkshopMay 7, 2025 | globenewswire.comVivani Medical, Inc. (NASDAQ:VANI) Short Interest UpdateVivani Medical, Inc. (NASDAQ:VANI - Get Free Report) saw a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 374,500 shares, an increase of 32.2% from the March 15th total of 283,300 shares. Currently, 1.2% of the company's shares are short sold. Based on an average daily volume of 100,100 shares, the short-interest ratio is presently 3.7 days.April 21, 2025 | marketbeat.comVivani Medical's (VANI) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright restated a "buy" rating and set a $4.00 target price on shares of Vivani Medical in a research report on Wednesday.April 18, 2025 | marketbeat.comVivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & CompanyApril 16, 2025 | finance.yahoo.comVivani Medical, Okava expand collaboration to develop OKV-119 for dogsApril 16, 2025 | markets.businessinsider.comVivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and LongevityApril 15, 2025 | globenewswire.comGregg Williams Purchases 18,529 Shares of Vivani Medical, Inc. (NASDAQ:VANI) StockApril 12, 2025 | insidertrades.comInsider Buying: Vivani Medical, Inc. (NASDAQ:VANI) Director Buys 34,000 Shares of StockVivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams purchased 34,000 shares of Vivani Medical stock in a transaction dated Friday, April 4th. The shares were bought at an average price of $0.99 per share, for a total transaction of $33,660.00. Following the acquisition, the director now owns 4,754,800 shares in the company, valued at approximately $4,707,252. This trade represents a 0.72 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website.April 10, 2025 | marketbeat.comInsider Buying: Vivani Medical, Inc. (NASDAQ:VANI) Director Acquires 44,400 Shares of StockVivani Medical, Inc. (NASDAQ:VANI - Get Free Report) Director Gregg Williams purchased 44,400 shares of the firm's stock in a transaction that occurred on Monday, April 7th. The stock was acquired at an average price of $0.99 per share, for a total transaction of $43,956.00. Following the completion of the purchase, the director now directly owns 4,799,200 shares of the company's stock, valued at $4,751,208. This represents a 0.93 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link.April 10, 2025 | marketbeat.comVivani Medical, Inc. (NASDAQ:VANI) Director Purchases $33,660.00 in StockApril 9, 2025 | insidertrades.comVivani Medical (NASDAQ:VANI) Given Buy Rating at HC WainwrightHC Wainwright restated a "buy" rating and issued a $4.00 price target on shares of Vivani Medical in a research report on Friday.April 6, 2025 | marketbeat.comWeight loss implants to increase compliance and cut admin burden for patientsApril 3, 2025 | finance.yahoo.comVivani Medical (NASDAQ:VANI) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPSVivani Medical (NASDAQ:VANI - Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.01).April 1, 2025 | marketbeat.comVivani Medical Reports 2024 Financial Results and Business ProgressApril 1, 2025 | tipranks.comVivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 31, 2025 | globenewswire.comVivani Medical prices 7.4M shares at $1.12 in private placement financingMarch 27, 2025 | markets.businessinsider.comVivani Medical, Inc.: Vivani Medical Announces $8.25M Private Placement Equity FinancingMarch 27, 2025 | finanznachrichten.deVivani Medical announces preclinical weight loss data for NPM-139March 27, 2025 | markets.businessinsider.comVivani Medical Gives Data for Weight Loss ImplantMarch 27, 2025 | finance.yahoo.comVivani Medical Announces Promising Preclinical Weight Loss Data For Its Semaglutide Implant: Retail Sentiment SoarsMarch 27, 2025 | msn.comVivani Medical Announces $8.25M Private Placement Equity FinancingMarch 27, 2025 | globenewswire.comVivani Withers on Data ReleaseMarch 26, 2025 | baystreet.caVivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly DosingMarch 26, 2025 | globenewswire.comVivani Medical to Present at the Emerging Growth Conference on March 27, 2025March 24, 2025 | businesswire.comVivani Medical (VANI) Expected to Announce Quarterly Earnings on TuesdayVivani Medical (NASDAQ:VANI) will be releasing earnings before the market opens on Tuesday, March 25, Financial Modeling Prep reports.March 18, 2025 | marketbeat.comBrokers Offer Predictions for Vivani Medical FY2024 EarningsVivani Medical, Inc. (NASDAQ:VANI - Free Report) - HC Wainwright dropped their FY2024 earnings per share (EPS) estimates for Vivani Medical in a note issued to investors on Thursday, March 13th. HC Wainwright analyst Y. Chen now forecasts that the company will post earnings of ($0.43) per share fMarch 17, 2025 | marketbeat.comVivani Medical (NASDAQ:VANI) Given "Buy" Rating at HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $4.00 price target on shares of Vivani Medical in a research note on Thursday.March 14, 2025 | marketbeat.comVivani Medical Stock Short Interest Report | NASDAQ:VANI | BenzingaMarch 14, 2025 | benzinga.comVivani Medical announces 1st GLP-1 implant in Liberate-1 clinical trialMarch 13, 2025 | markets.businessinsider.comVivani Medical to spin-off neurostim business Cortigent as public companyMarch 13, 2025 | msn.comVivani treats first patient with long-lasting drug implant for weight lossMarch 13, 2025 | finance.yahoo.comVivani Medical Achieves 1st Implant & Full Enrollment in Overweight TrialMarch 13, 2025 | finance.yahoo.comVivani Medical intends to spin off Cortigent divisionMarch 12, 2025 | markets.businessinsider.comVivani Medical to divest its neurostimulation devices businessMarch 12, 2025 | msn.comVivani Medical to Spin-Off Neurostimulation Division Cortigent for Nasdaq ListingMarch 12, 2025 | finance.yahoo.comVivani Medical Announces Intent to Spin Off Cortigent Neurostimulation BusinessMarch 12, 2025 | finance.yahoo.comEXCLUSIVE: Vivani Medical To Spin Off Cortigent Neurostimulation Business To Create Better Focus On Individual Entities And Shareholder ValueMarch 12, 2025 | benzinga.comShort Interest in Vivani Medical, Inc. (NASDAQ:VANI) Drops By 23.0%Vivani Medical, Inc. (NASDAQ:VANI - Get Free Report) was the recipient of a significant decrease in short interest in December. As of December 31st, there was short interest totalling 358,000 shares, a decrease of 23.0% from the December 15th total of 465,200 shares. Currently, 1.2% of the shares of the company are sold short. Based on an average daily trading volume, of 121,200 shares, the short-interest ratio is presently 3.0 days.January 15, 2025 | marketbeat.comVivani Medical: Strategic Innovation in GLP-1 Obesity Treatment Justifies Buy RatingDecember 22, 2024 | markets.businessinsider.comVivani begins exenatide implant trial for obesity in AustraliaDecember 20, 2024 | finance.yahoo.com Get Vivani Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter. Email Address VANI Media Mentions By Week VANI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VANI News Sentiment▼1.030.87▲Average Medical News Sentiment VANI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VANI Articles This Week▼61▲VANI Articles Average Week Get Vivani Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for VANI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ZIMV News Today NVRO News Today TCMD News Today DRTS News Today SKIN News Today BWAY News Today CATX News Today TLSI News Today LAKE News Today INGN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VANI) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredAs Bitcoin supply vanishes, this Trump-aligned token could explodeBitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivani Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vivani Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
